Self-Reported PrEP Intake Strongly Correlates With Actual Use
Self-reported PrEP intake in a diary app was strongly associated with blood concentrations reflecting actual PrEP intake in the previous 6 weeks.
Read More
Author: Teresa Sellinger
Reviewing Emerging Risk Factors for Psoriasis Flares
Researchers reviewed risk factors for psoriasis flares, including stress, infections, common drugs, pollution, hormonal changes, COVID-19, vaccines, and more.
Read More
Time of Day May Affect Asthma Diagnostic Test Results
Clinicians should account for the time of day when performing asthma diagnostic tests, as most patients experience more symptoms overnight and in the morning.
Read More
Using Sociodemographic Data to Predict Survival in Myelofibrosis
The first study to compare national myelofibrosis outcomes with a large minority cohort illustrates links between age, gender, and ethnicity and worse survival.
Read More
Addressing Non-Adherence & Motivating Patients to Take an Active Role in Their Health
Yvette C. Terrie, RPh, shares insights into addressing non-adherence and motivating patients to adhere to medication recommendations and health practices.
Read More
Is HFUS as Accurate as Pathology for Diagnosing Skin Cancer?
A recent study found that the accuracy of high-frequency ultrasound was similar to that of pathology for diagnosing basal cell and squamous cell carcinomas.
Read More
ICD-10 Update Season
Medical cartoon about ICD-10 codes raining down on the medical community during ICD-10-CM update season.
Read More
H2FPEF Score Improves Heart Failure Prediction in HCM
The H2FPEF score, a prognostic tool for diagnosing heart failure with preserved ejection fraction, proved useful for risk stratification in HCM.
Read More
2025 ICD-10-CM Codes Are Now in Effect: Key Updates You Need to Know
2025 ICD-10-CM updates include new codes, code deletions and revisions, and a conversion table that identifies inactive codes and their replacements.
Read More
Neoadjuvant Nivolumab/Ipilimumab Outperforms Adjuvant Anti-PD-1 Therapy in Stage III Resectable Melanoma
Recent research showed neoadjuvant therapy with 2 cycles of nivolumab/ipilimumab outperformed 12 courses of adjuvant nivolumab in stage III resectable melanoma.
Read More
Retifanlimab Improves Survival in Squamous Cell Carcinoma of the Anal Canal
Adding retifanlimab to standard-of-care chemotherapy improved response rate and progression-free survival in squamous cell carcinoma of the anal canal.
Read More
Addition of Chemoradiation to Neoadjuvant mFOLFIRINOX Shows No Benefit in BRPC
Results from the phase 2 PANDAS/PRODIGE 44 trial did not show any benefit from the addition of chemoradiation to neoadjuvant mFOLFIRINOX in patients with BRPC.
Read More
DESTINY-Breast12: T-DXd Exhibits Clinical Activity in HER2+ Breast Cancer Irrespective of Brain Metastases
T-DXd exhibited substantial and durable clinical activity in a large cohort of patients with metastatic HER2+ breast cancer, irrespective of brain metastases,
Read More
NVL-655: Promising New Option in Pretreated, Drug-Resistant ALK-Mutated NSCLC
In the phase 1/2 ALKOVE-1 trial, the ALK-selective tyrosine kinase inhibitor (TKI) NVL-655...
Read More
Looking Ahead: The Digital Future of Allergen Immunotherapy
The fields of allergy and immunology may soon see notable increases in mobile health allergy apps and AI use for monitoring treatment adherence and symptoms.
Read More
Strategies for Improving Guideline-Concordant Care in Lung Cancer
Survival in NSCLC improved with guideline-concordant care in lung cancer, and several factors can be addressed to reach more patients with such care.
Read More
Use of Nose Drops Reduces Length of Young Children’s Colds
Hypertonic saline nose drops effectively reduced the duration of symptoms associated with viral upper respiratory tract infections in children.
Read More
Obesity Tied to Pediatric Immune-Mediated Skin Diseases
Childhood obesity may increase the risk for pediatric immune-mediated skin diseases, including atopic dermatitis and psoriasis.
Read More
Single Dose of Mpox Vaccine Effective in At-Risk Groups
One dose of a modified mpox vaccine had a vaccine effectiveness of 58% in high-risk groups, including those with a history of an STI.
Read More
Readmission Varies By Discharge Setting for Sepsis Survivors
Risk for 30-day readmission is high and varies by setting for sepsis survivors discharged to skilled nursing facilities, home healthcare, and home.
Read More